Microbial factories for recombinant pharmaceuticals

Microbial Cell Factories

Volumn 8, Issue , 2009, Pages

  Ferrer Miralles, Neus ^a,b   Domingo Espín, Joan ^a,b   Corchero, José ^a,b   Vázquez, Esther ^a,b   Villaverde, Antonio ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; HUMAN GROWTH HORMONE; HUMULIN EU; HUMULIN US; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT HUMAN INSULIN; RECOMBINANT PROTEIN; RECOTHROM; UNCLASSIFIED DRUG; XYNTHA;

CAMPYLOBACTER JEJUNI; CHO CELL; DIABETES MELLITUS; DRUG APPROVAL; DRUG MARKETING; ESCHERICHIA COLI; HAMSTER; HUMAN; HYBRIDOMA; INSECT CELL; NONHUMAN; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RECOMBINANT DNA TECHNOLOGY; REVIEW; SACCHAROMYCES CEREVISIAE; TRANSGENIC ANIMAL; TRANSGENIC PLANT;

ESCHERICHIA COLI; MAMMALIA; SACCHAROMYCES;

EID: 65349147983     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-8-17     Document Type: Review

References (56)

1. Manning MC Patel K Borchardt RT Stability of protein pharmaceuticals Pharm Res 1989, 6:903-918 2687836
2. Human insulin receives FDA approval FDA Drug Bull 1982, 12:18-19 6762312
3. Redwan e Cumulative updating of approved biopharmaceuticals Hum Antibodies 2007, 16:137-158 18334749
4. Gerngross TU Advances in the production of human therapeutic proteins in yeasts and filamentous fungi Nat Biotechnol 2004, 22:1409-1414 15529166
5. Schmidt FR Recombinant expression systems in the pharmaceutical industry Appl Microbiol Biotechnol 2004, 65:363-372 15480623
6. Cusano AM Parrilli E Marino G Tutino ML A novel genetic system for recombinant protein secretion in the Antarctic Pseudoalteromonas haloplanktis TAC125 Microb Cell Fact 2006, 5:40 1766363 17169153
7. Parrilli E De VD Cirulli C Tutino ML Development of an improved Pseudoalteromonas haloplanktis TAC125 strain for recombinant protein secretion at low temperature Microb Cell Fact 2008, 7:2 2275215 18257924
8. Joosten V Lokman C Hondel Van Den CA Punt PJ The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi Microb Cell Fact 2003, 2:1 149433 12605725
9. Gasser B Maurer M Gach J Kunert R Mattanovich D Engineering of Pichia pastoris for improved production of antibody fragments Biotechnol Bioeng 2006, 94:353-361 16570317
10. Gasser B Mattanovich D Antibody production with yeasts and filamentous fungi: On the road to large scale? Biotechnol Lett 2007, 29:201-212 17120087
11. Meyer V Genetic engineering of filamentous fungi - progress, obstacles and future trends Biotechnol Adv 2008, 26:177-185 18201856
12. Schirrmann T Al-Halabi L Dubel S Hust M Production systems for recombinant antibodies Front Biosci 2008, 13:4576-4594 18508530
13. Jenkins N Modifications of therapeutic proteins: Challenges and prospects Cytotechnology 2007, 53:121-125 2267613 19003198
14. Walsh G Jefferis R Post-translational modifications in the context of therapeutic proteins Nat Biotechnol 2006, 24:1241-1252 17033665
15. Bailon P Won CY PEG-modified biopharmaceuticals Expert Opin Drug Deliv 2009, :1-16 19236204
16. Wacker M Linton D Hitchen PG Nita-Lazar M Haslam SM North SJ Panico M Morris HR Dell A Wren BW Aebi M N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli Science 2002, 298:1790-1793 12459590
17. Hite PF Barnes AMJPE Exhuberance Over Exubera Clinical Diabetes 2006, 24:110-114
18. Makrides SC Strategies for achieving high-level expression of genes in Escherichia coli Microbiol Rev 1996, 60:512-538 239455 8840785
19. Liao YD Jeng JC Wang CF Wang SC Chang ST Removal of N-terminal methionine from recombinant proteins by engineered E. coli methionine aminopeptidase Protein Sci 2004, 13:1802-1810 2279930 15215523
20. Gräslund S Nordlund P Weigelt J Hallberg BM Bray J Gileadi O Knapp S Oppermann U Arrowsmith C Hui R Ming J dhe-Paganon S Park HW Savchenko A Yee A Edwards A Vincentelli R Cambillau C Kim R Kim SH Rao Z Shi Y Terwilliger TC Kim CY Hung LW Waldo GS Peleg Y Albeck S Unger T Dym O et al Protein production and purification Nat Methods 2008, 5:135-146 18235434
21. Gasser B Saloheimo M Rinas U Dragosits M Rodríguez-Carmona E Baumann K Giuliani M Parrilli E Branduardi P Lang C Porro D Ferrer P Tutino ML Mattanovich D Villaverde A Protein folding and conformational stress in microbial cells producing recombinant proteins: A host comparative overview Microb Cell Fact 2008, 7:11 2322954 18394160
22. Prouty WF Karnovsky MJ Goldberg AL Degradation of abnormal proteins in Escherichia coli. Formation of protein inclusions in cells exposed to amino acid analogs J Biol Chem 1975, 250:1112-1122 1089651
23. Martinez-Alonso M Gonzalez-Montalban N Garcia-Fruitos E Villaverde A Learning about protein solubility from bacterial inclusion bodies Microb Cell Fact 2009, 8:4 2630952 19133126
24. Villaverde A Carrio MM Protein aggregation in recombinant bacteria: biological role of inclusion bodies Biotechnol Lett 2003, 25:1385-1395 14514038
25. Marston FA The purification of eukaryotic polypeptides synthesized in Escherichia coli Biochem J 1986, 240:1-12 1147368 3548705
26. Jana S Deb JK Strategies for efficient production of heterologous proteins in Escherichia coli Appl Microbiol Biotechnol 2005, 67:289-298 15635462
27. Sorensen HP Mortensen KK Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli Microb Cell Fact 2005, 4:1 544838 15629064
28. Nahalka J Vikartovska A Hrabarova E A crosslinked inclusion body process for sialic acid synthesis J Biotechnol 2008, 134:146-153 18313163
29. García-Fruitós E González-Montalbán N Morell M Vera A Ferraz RM Arís A Ventura S Villaverde A Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins Microb Cell Fact 2005, 4:27 1224866 16156893
30. Garcia-Fruitos E Aris A Villaverde A Localization of functional polypeptides in bacterial inclusion bodies Appl Environ Microbiol 2007, 73:289-294 1797118 17085715
31. Nahalka J Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-D:-Glucose-1-phosphate J Ind Microbiol Biotechnol 2008, 35:219-223 18087736
32. Nahalka J Dib I Nidetzky B Encapsulation of Trigonopsis variabilis D-amino acid oxidase and fast comparison of the operational stabilities of free and immobilized preparations of the enzyme Biotechnol Bioeng 2008, 99:251-260 17680679
33. Neubauer P Fahnert B Lilie h Villaverde A Protein inclusion bodies in recombinant bacteria. In Inclusions in Prokaryotes Microbiology Monographs Springer Shively JM 2006:237-292
34. Vallejo LF Rinas U Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins Microb Cell Fact 2004, 3:11 517725 15345063
35. Lin L Betaseron Dev Biol Stand 1998, 96:97-104 9890522
36. Redwan e Matar SM El-Aziz GA Serour EA Synthesis of the human insulin gene: Protein expression, scaling up and bioactivity Prep Biochem Biotechnol 2008, 38:24-39 18080908
37. RCSB Protein Data Bank 2008 http://www.rcsb.org
38. Target DB 2008 http://targetdb.pdb.org/
39. Graf A Gasser B Dragosits M Sauer M Leparc GG Tüchler T Kreil DP Mattanovich D Novel insights into the unfolded protein response using Pichia pastoris specific DNA microarrays BMC Genomics 2008, 9:390 2533675 18713468
40. Mattanovich D Gasser B Hohenblum H Sauer M Stress in recombinant protein producing yeasts J Biotechnol 2004, 113:121-135 15380652
41. Porro D Sauer M Branduardi P Mattanovich D Recombinant protein production in yeasts Mol Biotechnol 2005, 31:245-259 16230775
42. Branduardi P Smeraldi C Porro D Metabolically engineered yeasts: 'potential' industrial applications J Mol Microbiol Biotechnol 2008, 15:31-40 18349548
43. Gurramkonda C Adnan A Gäbel T Lünsdorf H Ross A Nemani SK Swaminathan S Khanna N Rinas U Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: Application to intracellular production of Hepatitis B surface antigen Microb Cell Fact 2009, 8:13 2646686 19208244
44. Singh S Gras A Fiez-Vandal C Ruprecht J Rana R Martinez M Strange PG Wagner R Byrne B Large-scale functional expression of WT and truncated human adenosine A2A receptor in Pichia pastoris bioreactor cultures Microb Cell Fact 2008, 7:28 2570359 18847468
45. Sinclair AM Elliott S Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins J Pharm Sci 2005, 94:1626-1635 15959882
46. Aumiller JJ Hollister JR Jarvis DL A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins Glycobiology 2003, 13:497-507 12626399
47. Hollister J Grabenhorst E Nimtz M Conradt H Jarvis DL Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans Biochemistry 2002, 41:15093-15104 12475259
48. Hollister JR Jarvis DL Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian beta 1,4-galactosyltransferase and alpha 2,6-sialyltransferase genes Glycobiology 2001, 11:1-9 11181556
49. Nissim A Chernajovsky Y Historical development of monoclonal antibody therapeutics Handb Exp Pharmacol 2008, 3:18 18071939
50. Bleckwenn NA Shiloach J Large-scale cell culture Curr Protoc Immunol 2004 Appendix 1 Appendix 18432919
51. Mohan C Kim YG Koo J Lee GM Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells Biotechnol J 2008, 3:624-630 18293320
52. Yuen CT Storring PL Tiplady RJ Izquierdo M Wait R Gee CK Gerson P Lloyd P Cremata JA Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures Br J Haematol 2003, 121:511-526 12716378
53. Staub JM Garcia B Graves J Hajdukiewicz PT Hunter P Nehra N Paradkar V Schlittler M Carroll JA Spatola L Ward D Ye G Russell DA High-yield production of a human therapeutic protein in tobacco chloroplasts Nat Biotechnol 2000, 18:333-338 10700152
54. Gonzalez-Montalban N Garcia-Fruitos E Villaverde A Recombinant protein solubility-does more mean better? Nat Biotechnol 2007, 25:718-720 17621288
55. de Marco A Protocol for preparing proteins with improved solubility by co-expressing with molecular chaperones in Escherichia coli Nat Protoc 2007, 2:2632-2639 17948006
56. de Marco A Minimal information: An urgent need to assess the functional reliability of recombinant proteins used in biological experiments Microb Cell Fact 2008, 7:20 2499994 18647423